Loading...
Nyxoah S.A.
NYXH•NASDAQ
Healthcare
Medical - Instruments & Supplies
$7.58
$-0.21(-2.70%)
Nyxoah S.A. (NYXH) Financial Performance & Income Statement Overview
Review Nyxoah S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.98%
↑ 3.98%
Operating Income Growth
-30.39%
↓ 30.39%
Net Income Growth
-37.08%
↓ 37.08%
Operating Cash Flow Growth
-9.93%
↓ 9.93%
Operating Margin
-1540.72%
↓ 1540.72%
Gross Margin
65.54%
↑ 65.54%
Net Profit Margin
-1597.50%
↓ 1597.50%
ROE
-64.70%
↓ 64.70%
ROIC
-58.50%
↓ 58.50%
Nyxoah S.A. (NYXH) Income Statement & Financial Overview
Review Nyxoah S.A.'s (NYXH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.26M | $1.27M | $771000.00 | $1.22M |
| Cost of Revenue | $335000.00 | $482000.00 | $281000.00 | $1.06M |
| Gross Profit | $928000.00 | $784000.00 | $490000.00 | $156000.00 |
| Gross Profit Ratio | $0.73 | $0.62 | $0.64 | $0.13 |
| R&D Expenses | $11.75M | $7.93M | $7.47M | $6.87M |
| SG&A Expenses | $8.06M | $7.71M | $6.38M | $5.70M |
| Operating Expenses | $19.24M | $15.76M | $13.80M | $12.56M |
| Total Costs & Expenses | $19.57M | $16.25M | $14.08M | $13.63M |
| Interest Income | $829000.00 | $703000.00 | $2.07M | $498000.00 |
| Interest Expense | $534000.00 | $672000.00 | $1.45M | $359000.00 |
| Depreciation & Amortization | $216000.00 | $334000.00 | $660000.00 | $610000.00 |
| EBITDA | -$18.09M | -$15.88M | -$11.24M | -$11.80M |
| EBITDA Ratio | -$14.33 | -$12.54 | -$14.58 | -$9.66 |
| Operating Income | -$18.31M | -$14.98M | -$13.31M | -$12.41M |
| Operating Income Ratio | -$14.50 | -$11.83 | -$17.26 | -$10.16 |
| Other Income/Expenses (Net) | $3.24M | -$1.91M | $624000.00 | $417000.00 |
| Income Before Tax | -$15.07M | -$16.89M | -$12.68M | -$11.80M |
| Income Before Tax Ratio | -$11.93 | -$13.34 | -$16.45 | -$9.66 |
| Income Tax Expense | $2.08M | $173000.00 | $441000.00 | $110000.00 |
| Net Income | -$17.15M | -$17.06M | -$13.12M | -$11.91M |
| Net Income Ratio | -$13.58 | -$13.47 | -$17.02 | -$9.75 |
| EPS | -$0.46 | -$0.50 | -$0.43 | -$0.42 |
| Diluted EPS | -$0.46 | -$0.50 | -$0.43 | -$0.42 |
| Weighted Avg Shares Outstanding | $37.04M | $34.38M | $30.74M | $28.68M |
| Weighted Avg Shares Outstanding (Diluted) | $37.04M | $34.38M | $30.74M | $28.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan